Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
With MDCG guidance on change control promised by year’s end, notified bodies and experts weigh in on how much latitude device and digital health firms should have in making product modifications, and where PCCPs fit in. Europe could offer more room than the US for continuous innovation—if it can settle on which changes need notified body approval.
LIOM is developing a wearable that can in real time noninvasively sense glucose and other molecules to help people—consumers, patients, researchers, and clinicians—make connections between biomarkers, behavior, and health.
FDA lends a hand to companies pursuing De Novo authorization. Excerpted from Pathways’ Picks October 21: CDRH Hiring, EU Reform Timeline, AI Policy Plans, and More.